Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: IMARC | PRODUCT CODE: 1450977

Cover Image

PUBLISHER: IMARC | PRODUCT CODE: 1450977

Next-Generation Sequencing Market Report by Sequencing Type, Product Type, Technology, Application, End-User, and Region 2024-2032

PUBLISHED:
PAGES: 142 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 3899
PDF & Excel (5 User License)
USD 4899
PDF & Excel (Corporate License)
USD 5899

Add to Cart

The global next-generation sequencing (NGS) market size reached US$ 20.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 80.4 Billion by 2032, exhibiting a growth rate (CAGR) of 16.2% during 2024-2032.

Next-generation sequencing (NGS) is a parallel sequencing technology that determines the sequence of nucleotides in a section of the deoxyribonucleic acid (DNA). It involves various procedures, such as sequencing by synthesis (SBS) and ion semiconductor, single-molecule real-time (SMRT), and nanopore sequencing. It is a cost-effective solution that assists medical professionals in achieving precise results with high accuracy and speed. It also facilitates research in the fields of clinical diagnostics, personalized and genetic medicines, and agriculture and animal studies. At present, it is utilized in pharmacogenomics to escalate the drug delivery process.

Next-Generation Sequencing (NGS) Market Trends:

The growing global geriatric population and the rising prevalence of various chronic medical disorders, such as cancer, cardiovascular, and neurological disorders, represent one of the key factors positively influencing the market. It can also be attributed to the growing use of genetic maps for guiding scientists to analyze the genes that are responsible for medical conditions. In addition, the widespread adoption of liquid biopsies in cancer diagnostics and the increasing utilization of NGS technologies to introduce non-invasive cancer biomarkers for real-time cancer monitoring and detection are creating a positive market outlook. In line with this, continuous technological innovations in sequencers, such as the integration of cloud-computing systems for enhanced data security and management, are strengthening the market growth. Apart from this, continuous financing by governments of various countries to improve healthcare infrastructure is providing a thrust to the market growth. Furthermore, increasing investments by leading players in research and development (R&D) activities for molecular biology, technical engineering, and sequencing chemistry is offering a favorable market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global next-generation sequencing (NGS) market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on sequencing type, product type, technology, application and end-user.

Breakup by Sequencing Type:

Whole Genome Sequencing

Targeted Resequencing

Whole Exome Sequencing

RNA Sequencing

CHIP Sequencing

De Novo Sequencing

Methyl Sequencing

Others

Targeted resequencing represents the largest market segment due to the presence of numerous companies in the NGS market offering targeted resequencing services.

Breakup by Product Type:

Instruments

Reagents and Consumables

Software and Services

Reagents and consumables represent the most commonly used product type that assists in sample preparation, DNA isolation, sample cleanup, target enrichment, and quality assurance.

Breakup by Technology:

Sequencing by Synthesis

Ion Semiconductor Sequencing

Single-Molecule Real-Time Sequencing

Nanopore Sequencing

Others

Sequencing by synthesis finds extensive applications on account of its high accuracy in performing DNA sequencing and its growing incorporation in NGS instrumentation. In addition, it offers the highest yield of error-free throughput results.

Breakup by Application:

Biomarker and Cancer

Drug Discovery and Personalized Medicine

Genetic Screening

Diagnostics

Agriculture and Animal Research

Others

Biomarker and cancer currently dominate the market due to the rising prevalence of cancer and increasing awareness among individuals about the benefits of early diagnosis and treatment.

Breakup by End-User:

Academic Institutes & Research Centers

Hospitals & Clinics

Pharmaceutical & Biotechnology Companies

Others

Academic institutes and research centers account for the majority of the market share due to the increasing application of NGS solutions in research projects.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market due to the availability of a technologically advanced healthcare research framework in the region, coupled with the presence of multiple clinical laboratories that employ NGS to provide genetic testing services.

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies, Becton Dickinson and Company, 10x Genomics, BGI Group, Eurofins Scientific, F. Hoffmann-La Roche AG, Illumina Inc., Genewiz, Macrogen, Oxford Nanopore Technologies, Pacific Biosciences, PerkinElmer, Thermo Fisher Scientific, Qiagen N.V., GenapSys Inc., etc.

Key Questions Answered in This Report

  • 1. What was the size of the global next-generation sequencing (NGS) market in 2023?
  • 2. What is the expected growth rate of the global next-generation sequencing (NGS) market during 2024-2032?
  • 3. What are the key factors driving the global next-generation sequencing (NGS) market?
  • 4. What has been the impact of COVID-19 on the global next-generation sequencing (NGS) market?
  • 5. What is the breakup of the global next-generation sequencing (NGS) market based on the sequencing type?
  • 6. What is the breakup of the global next-generation sequencing (NGS) market based on the product type?
  • 7. What is the breakup of the global next-generation sequencing (NGS) market based on the technology?
  • 8. What is the breakup of the global next-generation sequencing (NGS) market based on the application?
  • 9. What is the breakup of the global next-generation sequencing (NGS) market based on the end- user?
  • 10. What are the key regions in the global next-generation sequencing (NGS) market?
  • 11. Who are the key players/companies in the global next-generation sequencing (NGS) market?
Product Code: SR112024A2039

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Next-Generation Sequencing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Sequencing Type

  • 6.1 Whole Genome Sequencing
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Targeted Resequencing
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Whole Exome Sequencing
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 RNA Sequencing
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 CHIP Sequencing
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 De Novo Sequencing
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Methyl Sequencing
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Product Type

  • 7.1 Instruments
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Reagents and Consumables
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Software and Services
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Sequencing by Synthesis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ion Semiconductor Sequencing
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Single-Molecule Real-Time Sequencing
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Nanopore Sequencing
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Biomarker and Cancer
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Drug Discovery and Personalized Medicine
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Genetic Screening
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Diagnostics
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Agriculture and Animal Research
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 Others
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Academic Institutes & Research Centers
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals & Clinics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Pharmaceutical & Biotechnology Companies
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Agilent Technologies Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Becton Dickinson and Company
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 10x Genomics
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 BGI Group
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Eurofins Scientific
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 F. Hoffmann-La Roche AG
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
    • 16.3.7 Illumina Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Genewiz
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Macrogen Inc.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
    • 16.3.10 Oxford Nanopore Technologies
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis
    • 16.3.11 Pacific Biosciences
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
    • 16.3.12 Perkinelmer Inc.
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Thermo Fisher Scientific Inc.
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials
      • 16.3.13.4 SWOT Analysis
    • 16.3.14 Qiagen N.V.
      • 16.3.14.1 Company Overview
      • 16.3.14.2 Product Portfolio
      • 16.3.14.3 Financials
      • 16.3.14.4 SWOT Analysis
    • 16.3.15 Genapsys Inc.
      • 16.3.15.1 Company Overview
      • 16.3.15.2 Product Portfolio
Product Code: SR112024A2039

List of Figures

  • Figure 1: Global: Next-Generation Sequencing Market: Major Drivers and Challenges
  • Figure 2: Global: Next-Generation Sequencing Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Next-Generation Sequencing Market: Breakup by Sequencing Type (in %), 2023
  • Figure 4: Global: Next-Generation Sequencing Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Next-Generation Sequencing Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Next-Generation Sequencing Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Next-Generation Sequencing Market: Breakup by End-User (in %), 2023
  • Figure 8: Global: Next-Generation Sequencing Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Next-Generation Sequencing Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 10: Global: Next-Generation Sequencing (Whole Genome Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Next-Generation Sequencing (Whole Genome Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Next-Generation Sequencing (Targeted Resequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Next-Generation Sequencing (Targeted Resequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Next-Generation Sequencing (Whole Exome Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Next-Generation Sequencing (Whole Exome Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Next-Generation Sequencing (RNA Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Next-Generation Sequencing (RNA Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Next-Generation Sequencing (CHIP Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Next-Generation Sequencing (CHIP Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Next-Generation Sequencing (De Novo Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Next-Generation Sequencing (De Novo Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Next-Generation Sequencing (Methyl Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Next-Generation Sequencing (Methyl Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Next-Generation Sequencing (Other Sequencing Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Next-Generation Sequencing (Other Sequencing Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Next-Generation Sequencing (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Next-Generation Sequencing (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Next-Generation Sequencing (Reagents and Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Next-Generation Sequencing (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Next-Generation Sequencing (Software and Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Next-Generation Sequencing (Software and Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Next-Generation Sequencing (Sequencing by Synthesis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Next-Generation Sequencing (Sequencing by Synthesis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Next-Generation Sequencing (Ion Semiconductor Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Next-Generation Sequencing (Ion Semiconductor Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Next-Generation Sequencing (Single-Molecule Real-Time Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Next-Generation Sequencing (Single-Molecule Real-Time Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Next-Generation Sequencing (Nanopore Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Next-Generation Sequencing (Nanopore Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Next-Generation Sequencing (Biomarker and Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Next-Generation Sequencing (Biomarker and Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: Next-Generation Sequencing (Drug Discovery and Personalized Medicine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: Next-Generation Sequencing (Drug Discovery and Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Global: Next-Generation Sequencing (Genetic Screening) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Global: Next-Generation Sequencing (Genetic Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Global: Next-Generation Sequencing (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Global: Next-Generation Sequencing (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Global: Next-Generation Sequencing (Agriculture and Animal Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Global: Next-Generation Sequencing (Agriculture and Animal Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Global: Next-Generation Sequencing (Academic Institutes & Research Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Global: Next-Generation Sequencing (Academic Institutes & Research Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Global: Next-Generation Sequencing (Hospitals & Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Global: Next-Generation Sequencing (Hospitals & Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Global: Next-Generation Sequencing (Pharmaceutical & Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Global: Next-Generation Sequencing (Pharmaceutical & Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: North America: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: North America: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: United States: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: United States: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Canada: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Canada: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Asia Pacific: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Asia Pacific: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: China: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: China: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Japan: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Japan: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: India: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: India: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: South Korea: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: South Korea: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Australia: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Australia: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Indonesia: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Indonesia: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Others: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Others: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Europe: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Europe: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Germany: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Germany: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: France: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: France: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: United Kingdom: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 91: United Kingdom: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 92: Italy: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 93: Italy: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 94: Spain: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 95: Spain: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 96: Russia: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 97: Russia: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 98: Others: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 99: Others: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 100: Latin America: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 101: Latin America: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 102: Brazil: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 103: Brazil: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 104: Mexico: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 105: Mexico: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 106: Others: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 107: Others: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 108: Middle East and Africa: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 109: Middle East and Africa: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 110: Global: Next-Generation Sequencing Industry: SWOT Analysis
  • Figure 111: Global: Next-Generation Sequencing Industry: Value Chain Analysis
  • Figure 112: Global: Next-Generation Sequencing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Next-Generation Sequencing Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Next-Generation Sequencing Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Next-Generation Sequencing Market Forecast: Breakup by Sequencing Type (in Million US$), 2024-2032
  • Table 4: Global: Next-Generation Sequencing Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 5: Global: Next-Generation Sequencing Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Next-Generation Sequencing Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 7: Global: Next-Generation Sequencing Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Next-Generation Sequencing Market Structure
  • Table 9: Global: Next-Generation Sequencing Market: Key Players
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!